Previously, Luo gounov, deputy director of the National Research Center for epidemiology and microbiology in gamaliya, Russia, said that the center is expected to obtain the civil circulation license for the new coronavirus vaccine from September 10 to 13, when it can start vaccinating the public. < / P > < p > on August 11, the Russian Ministry of health registered the world’s first vaccine to prevent new coronavirus infection, which was jointly developed by the National Research Center of epidemiology and microbiology of gamaliya and the Russian direct investment fund. The vaccine was named “satellite-v”. Dmitriev, President of the Russian direct investment fund, said that the fund has received applications from more than 20 countries to buy 1 billion doses of vaccine. He also pointed out that Russia has agreed to produce vaccines in five countries, and the existing capacity will reach 500 million doses per year.